MoneyGram sells $50m stake to Ripple, will use XRP on its platform
By Akshay Kedari  Date: 2019-06-19

MoneyGram sells $50m stake to Ripple, will use XRP on its platform

The partnership will end the need to deploy foreign bank accounts, a reason why MoneyGram has a negative working capital

Ripple, the cryptocurrency company, has recently announced that it has teamed up with MoneyGram, a money transfer platform, in a partnership that will see MoneyGram’s services use digital currency XRP in day to day operations.

According to the terms stated in the deal, Ripple will pay $4.10 cents per share in order to acquire an 8% to 10% of stake in MoneyGram. In other words, Ripple is making an investment of $30 million and would be giving MoneyGram the option of additional cash infusion of $20 million in the next two years.

Apparently, the deal is going to provide Ripple with unparalleled opportunities to advocate the use of X-Rapid, a product which allows XRP transfer, it claims is superior in movement of money across borders. Ripple has long been against banks leaving money as collateral in foreign accounts and suggested the use of XRP in the form of bridge currency.

Brad Garlinghouse, CEO of Ripple said that the partnership will end the need to deploy foreign bank accounts, which is also the reason why MoneyGram has a negative working capital. The product will help smooth the treasury operations of customers, Garlinghouse added.

Reportedly, the investment in MoneyGram took place after its rival Western Union terminated a trial experiment with XRapid, stating that XRP transfer service did not produce any major savings. Despite being part of several pilot projects, XRP has not attained any breakout moment yet.

However, the CEO of Ripple claims that hundreds of partners have been using XRP in the recent months, with the implied value of the crypto being $18 billion, placing it as the third most valuable cryptocurrency after Ethereum and Bitcoin.

Citing reliable sources, Ripple is not going to secure a seat on the MoneyGram Board as of now but will attain the status of an observer.

 

Source Credit- http://fortune.com/2019/06/17/ripple-moneygram-xrp/

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...